FDA Approvals - UCB's Vimpat Approved By U.S. FDA As Adjunctive Therapy For
UCB's Vimpat Approved By U.S. FDA As Adjunctive Therapy For Partial Onset Seizures In Adults (Medical News Today)
UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Vimpat (lacosamide), a new antiepileptic drug (AED). Vimpat is for use as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older.
FDA Warns Bayer About Two Illegal Aspirins (Medical News Today)
The US Food and Drug Administration (FDA) has written warning letters to drug company Bayer HealthCare about two over the counter (OTC) aspirins that contain supplements and claim to be effective not only for pain relief but against heart disease, and this constitutes a use for which the drug